Amrutanjan Health Care Limited has paid lease rent arrears of ₹9,74,67,151 to Kapaleeswarar Temple, complying with an order from the Madras High Court. The payment was executed on August 1, 2026, subject to Tax Deduction at Source, resolving a long-standing legal dispute regarding the validity of lease charges under state endowment laws. The company stated that the settlement does not significantly impact its business or operations.

The disclosure was made under Regulation 30 read with Clause 20 of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The payment fulfills the directive issued by the Hon'ble Madras High Court in Writ Petition No. 35484 of 2005 and its related appeal. The court had previously dismissed the company's challenge to the proviso to Section 34A(5) of the Tamil Nadu Hindu Religious and Charitable Endowment Act 1959, ruling it neither illegal nor ultra vires.

The Madras High Court order, dated March 17, 2026, mandated the payment by August 2, 2026. Amrutanjan Health Care Limited completed the transaction ahead of this deadline. The legal proceedings centered on the company's attempt to declare the specific section of the endowment act unenforceable as it applied to the firm's lease arrangements.

Legal and Financial Details

The following details outline the regulatory compliance and financial specifics of the settlement:

The company cited SEBI Circular no. SEBI/HO/CFD/CFD-PoD-I/P/CIR/2023/123 dated July 13, 2023, for the structured disclosure of these details. The dismissal of the writ petition confirmed the enforceability of the lease rent provisions under the state act.

What the Numbers Show

The settlement of ₹9.74 crore represents a one-time cash outflow to resolve a legacy legal liability. By executing the payment before the August 2 deadline, the company avoided potential enforcement actions or penalties associated with non-compliance. The management's assertion that there is "no significant impact" suggests the amount is manageable within the company's current liquidity position, allowing operations to continue without disruption while closing this chapter of litigation.

Amrutanjan Health Care Limited shareholders have approved the appointment of two Non-Executive Independent Directors for five-year terms through a remote e-voting process. The resolutions sought the appointment of Dr. Ramaswami Krishnan and the re-appointment of Mr. Swayambunathan Muralidharan, both receiving strong shareholder support.

The postal ballot notice was sent to 44,847 shareholders on May 18, 2026. The remote e-voting period commenced on May 19, 2026, and concluded on June 18, 2026. A total of 228 shareholders participated, casting 15,869,989 votes. The scrutinizer's report confirmed that no votes were received through physical mode or deemed invalid.

Voting Results

The first resolution proposed the appointment of Dr. Ramaswami Krishnan (DIN: 08562199) for a term of five consecutive years. The resolution received 99.99% approval, with 15,867,957 votes in favour and 2,032 votes against.

The second resolution concerned the re-appointment of Mr. Swayambunathan Muralidharan (DIN: 09198315) for a second term of five consecutive years. This resolution was approved by 99.8% of the votes polled, with 15,837,751 votes in favour and 32,238 votes against.

Breakdown of Votes

Dr. Ramaswami Krishnan was appointed as an Additional Director effective May 8, 2026, and his tenure as Independent Director will extend up to May 7, 2031. Mr. Swayambunathan Muralidharan's re-appointment is effective from June 29, 2026, to June 28, 2031. The approvals were pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.